ANALYSIS
Methodology note: Historical index values on this Pulse are normalized to the current methodology for comparability. The original as-published record remains unchanged in the canonical archive.
Executive signal
One material frontier-model release was initially missed by the automated review and is corrected here: SpaceXAI released Grok 4.6 on 12 August. Independent evaluation reporting places it roughly five Artificial Analysis Intelligence Index points above Grok 4.5, around GPT-5.6 Sol overall and especially strong on agentic work. The release materially strengthens SpaceXAI's position but does not establish a new absolute capability ceiling, so ASI Readiness and the rolling ASI forecast remain unchanged.
Frontier Intelligence / Agents / Coding / AI-R&D
Material event — Grok 4.6: SpaceXAI released Grok 4.6 on 12 August. Independent reporting citing Artificial Analysis says it improves about five points over Grok 4.5 on the Intelligence Index, sits around GPT-5.6 Sol overall, and is particularly strong on agentic tasks while remaining cost-efficient. Relevance: 8.5/10. ASI impact: +2/10 signal strength, but no readiness or forecast change because it does not clearly exceed the current overall capability ceiling.
AI for Science
Material events: none verified in-window. VibeMathed showed no newly dated 12–13 Aug resolution in the indexed public list; existing entries retain their prior verification states. No new independently validated scientific result justified a Science maturity change. ASI impact: 0.
Generalist Robotics
Material events: none verified in-window. No new primary-source evidence established a material improvement in intervention rate, unattended duration, cross-task generalization, reliability, deployment scale or cost. ASI impact: 0.
Compute & Infrastructure
Material events: none verified in-window. Rubin and MI400/MI455X remain the current frontier infrastructure context, but no new 24-hour development materially changed accelerator capability, HBM/interconnect, advanced packaging, fab capacity, datacenter power or economics. ASI overlay impact: 0.
Synthetic Biology / Gene Engineering
Material events: none verified in-window. No new clinical endpoint, regulatory decision, delivery breakthrough, or closed-loop wet-lab result from the monitored leaders justified a frontier change. Frontier impact: 0.
Energy / Fusion
Material events: none verified in-window. No monitored program reported a new plasma milestone that changes commercial readiness, and—more importantly—no integrated net-electricity, plant availability, lifetime or bankable $/MWh milestone was verified. Frontier impact: 0.
Advanced Materials
Material events: none verified in-window. No new result closed the key gap from computational discovery to reproducible synthesis, qualification and manufacturing scale. Frontier impact: 0.
Longevity
Material events: none verified in-window. ER-100 remains Phase 1; no new safety, efficacy or rejuvenation endpoint was reported in the review window. No monitored program produced human evidence strong enough to change maturity. Frontier impact: 0.
BCI / HMI
Material events: none verified in-window. No new human bandwidth, bidirectionality, stability, patient-count or durable real-world-use result crossed the materiality threshold. Frontier impact: 0.
Benchmark observatory
METR Time Horizon remains at its latest published measurement set (last updated 8 May 2026). No in-window benchmark-health change was found that would justify a new point or score movement. No synthetic substitute benchmark was created.
Current state — unchanged
ASI rolling probability — unchanged
No new rows were added to `asi_forecast_history`, because no evidence justified a forecast revision.
Main signals / bottlenecks to watch
1. Long-horizon autonomous reliability and low-intervention task duration. 2. Closure of the automated AI-R&D loop: propose → implement → evaluate → iterate. 3. Independent validation of AI-generated scientific results and closed-loop laboratory execution. 4. Robot uptime, intervention rate, generalization and production economics at real deployment scale. 5. Datacenter power, HBM/interconnect and leading-edge fab/advanced-packaging capacity. 6. Integrated commercial fusion net-electricity, maintainability and plant economics rather than plasma-only milestones. 7. Materials validation-to-manufacturing throughput. 8. Programmable-biology delivery/control and human clinical validation. 9. Human rejuvenation endpoints beyond biomarkers or preclinical results. 10. Stable, high-bandwidth, durable and increasingly bidirectional BCI use in humans.
Primary pages checked / anchors
OpenAI News; Anthropic News; Google DeepMind models/research; SpaceXAI news/docs; DeepSeek changelog; Alibaba Model Studio lifecycle; VibeMathed; METR Time Horizon; NVIDIA Rubin; AMD MI400; CFS and Helion newsrooms; Life Biosciences trial/news pages; Synchron and Paradromics clinical/product pages; Microsoft Research Materials / Materials Project.